跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92,874 条关于
“complement-mediated disease”
全部
92,874
临床试验
69,272
药物
1,524
机构
177
资讯
21,901
去年
Novartis' FABHALTA Poised to Transform Treatment Landscape for Multiple Complement-Mediated Diseases
3天前
One04 Therapeutics Launches on Encouraging CPV-104 Phase 1 Interim Data in C3 Glomerulopathy
上个月
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
11个月前
ADARx Pharmaceuticals to Present Phase 1 Data for ADX-038 siRNA Therapy at ASN Kidney Week 2025
去年
Argo Biopharma Advances siRNA Therapy BW-40202 to Phase II Trial for Paroxysmal Nocturnal Hemoglobinuria
8个月前
Omeros Receives FDA Approval for First-in-Class TA-TMA Therapy YARTEMLEA
前天
Akebia Doses First Patient in Phase 2 Basket Trial of Ebribafusp for Rare Complement-Mediated Kidney Diseases
去年
Arrowhead's ARO-C3 Shows Promising Results in IgA Nephropathy Trial with 89% Reduction in C3 Levels
7个月前
RNA Interference Therapy Market Expands with 90+ Drugs in Development Across 40+ Companies
去年
ImmunAbs Receives FDA Clearance for Phase 2 Trial of IM-101 Complement Inhibitor in Myasthenia Gravis
第 1 页，共 2191 页
上一页
下一页
